See the DrugPatentWatch profile for yervoy

Based on the information available, I cannot provide an exact cost for a generic version of Yervoy, as it is currently not available on the market. Yervoy, also known as ipilimumab, is a medication produced by Bristol Myers Squibb and is used to treat melanoma and other types of cancer. It is a monoclonal antibody that works by boosting the body's immune system to help fight cancer cells.

According to the drug patent watchdog website DrugPatentWatch.com, Yervoy is currently under patent protection until 2028 [1]. This means that no generic versions of the drug can be produced or sold in the United States until that time.

It is worth noting that the cost of brand-name Yervoy can be quite high. According to GoodRx, the cost of Yervoy can range from $8,000 to $14,000 for a typical 3 mg dose, depending on the pharmacy and location [2].

Once generic versions of Yervoy become available, they are likely to be less expensive than the brand-name version. However, it is difficult to predict exactly how much they will cost. Generic drug prices can vary based on a number of factors, including competition among manufacturers, insurance coverage, and other market forces.

In summary, while it is not possible to provide an exact cost for a generic version of Yervoy at this time, it is likely that generic versions will be less expensive than the brand-name drug once they become available.

Sources:

1. DrugPatentWatch.com, Ipilimumab (Yervoy) Patent Expiration & Generic Entry, <https://www.drugpatentwatch.com/ipilimumab-yervoy-patent-expiration-generic-entry/>
2. GoodRx, Yervoy (Ipilimumab) Prices, Coupons and Patient Assistance Programs, <https://www.goodrx.com/yervoy>